Base period

Ended Awarded Last action

Contract number
0019
Awardee
Awarding agency
Obligated
$4,402,389

Award facts

Opportunity
Contract value 95% obligated
  • $4,402,389.00 Current, with exercised options
  • $4,636,158.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 11 $0
Funding Only Action 10 · Research and development services efficacy of finafloxacin against biological threat agents $880,644
Supplemental Agreement for work within scope 9 $0
Supplemental Agreement for work within scope 8 · Research and development contract to study efficacy of finafloxacin against biological threat agents. $673,277
Funding Only Action 7 $900,000
Exercise an Option 6 $225,000
Supplemental Agreement for work within scope 5 $0
Funding Only Action 4 $481,593
Funding Only Action 3 $200,000
Other Administrative Action 2 · Efficacy of finafloxacin against biological threat agents. $0
Funding Only Action 1 $200,000
Original award $841,875
Show all 12

About this award

Written by GovTribe AI ·

This is a federal contract award to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The $4,636,158.00 cost-plus-fixed-fee contract was awarded by the Defense Threat Reduction Agency (DTRA) with a period of performance ending on September 30, 2022. The contract has no set-aside designation.

DSTL is an experienced provider of advanced research and development services to U.S. federal agencies, with a focus on countering chemical, biological, radiological, and nuclear threats. The organization has secured multiple high-value contracts with DTRA and the Department of Homeland Security Science and Technology Directorate, covering a range of complex research initiatives such as developing medical countermeasures and drug delivery systems. Additionally, DSTL holds a seven-year, $146.3 million Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases (NIAID) for providing pre-clinical research models to evaluate countermeasures against infectious agents, including those with pandemic potential.

Quick answers

Who was awarded contract 0019?

0019 was awarded to Ministry Of Defence by Defense Threat Reduction Agency (Department of Defense) on October 31, 2016.

How much is contract 0019 worth?

The government has obligated $4,402,389 on 0019. Its potential value, with all options, is $4,636,158.

Is contract 0019 an order under another contract?

Yes. 0019 is a delivery order under HDTRA112D0003, an indefinite delivery contract.

Was contract 0019 competed?

The extent of competition for 0019 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login